Cerus Corporation (CERS): Price and Financial Metrics
Cerus Corporation (CERS)
Today's Latest Price: $6.83 USD
0.17 (-2.43%)
Updated Jul 10 4:00pm
Add CERS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CERS Stock Summary
- Of note is the ratio of Cerus Corp's sales and general administrative expense to its total operating expenses; 28.63% of US stocks have a lower such ratio.
- CERS's price/sales ratio is 11.61; that's higher than the P/S ratio of 88.64% of US stocks.
- As for revenue growth, note that CERS's revenue has grown 19.08% over the past 12 months; that beats the revenue growth of 77.89% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Cerus Corp, a group of peers worth examining would be PSNL, JG, KIN, MRAM, and CTIC.
- CERS's SEC filings can be seen here. And to visit Cerus Corp's official web site, go to www.cerus.com.
CERS Daily Price Range
CERS 52-Week Price Range
CERS Stock Price Chart Technical Analysis Charts
CERS Price/Volume Stats
| Current price | $6.83 | 52-week high | $7.49 |
| Prev. close | $7.00 | 52-week low | $2.71 |
| Day low | $6.82 | Volume | 1,357,270 |
| Day high | $7.00 | Avg. volume | 1,985,806 |
| 50-day MA | $6.10 | Dividend yield | N/A |
| 200-day MA | $4.93 | Market Cap | 1.12B |
Cerus Corporation (CERS) Company Bio
Cerus Corporation operates as a biomedical products company which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company was founded in 1991 and is based in Concord, California.
Loading social stream, please wait...